Application for approval for adults unable to consent to their own treatment to participate in a clinical trial (AMOUNT Rehabilitation Trial)

Case

[2015] NSWCATGD 1

06 January 2015


Details
AGLC Case Decision Date
Application for approval for adults unable to consent to their own treatment to participate in a clinical trial (AMOUNT Rehabilitation Trial) [2015] NSWCATGD 1 [2015] NSWCATGD 1 06 January 2015

CaseChat Overview and Summary

In the Federal Court of Australia, the application for approval of a clinical trial involving adults unable to consent was brought forward. The trial, known as the AMOUNT Rehabilitation Trial, aimed to test the efficacy of commercially available technologies for rehabilitation through a process of randomisation. The applicant sought approval for this trial under the National Health and Medical Research Council (NHMRC) guidelines, with the function of providing or withholding consent to be exercised by a designated 'person responsible'. The court was tasked with determining whether the proposed trial qualified as a clinical trial and if it was appropriate for the 'person responsible' to give or withhold consent on behalf of the adults unable to consent.

The primary legal issues addressed by the court were whether the AMOUNT Rehabilitation Trial met the definition of a clinical trial and if it was appropriate for a 'person responsible' to make decisions regarding participation in the trial for adults who were unable to consent. The court examined the NHMRC guidelines to ascertain the parameters for what constitutes a clinical trial and considered the ethical and procedural implications of delegating the consent function to a 'person responsible'. The court also evaluated the safeguards and protections in place to ensure that the rights and welfare of the participants were adequately safeguarded.

After a thorough examination of the guidelines and the specific circumstances of the trial, the court concluded that the AMOUNT Rehabilitation Trial indeed qualified as a clinical trial. The court found that the process of randomisation and the investigation of commercially available technologies for rehabilitation aligned with the criteria for a clinical trial. Furthermore, the court determined that it was appropriate for a 'person responsible' to exercise the function of giving or withholding consent on behalf of the participants who were unable to consent. The court found that the mechanisms in place to ensure the 'person responsible' acted in the best interests of the participants were sufficient. Consequently, the court approved the trial, allowing adults unable to consent to participate, with the consent function exercised by a 'person responsible' as outlined in the NHMRC guidelines.

The court's final order was to approve the AMOUNT Rehabilitation Trial as a clinical trial. The trial could proceed with the participation of adults unable to consent, and the 'person responsible' was authorised to give or withhold consent on their behalf. This decision ensured that the trial could move forward while maintaining ethical standards and protecting the rights of the participants.
Details

Areas of Law

  • Medical Law

Legal Concepts

  • Clinical Trial

  • Consent

  • Unconscionable Conduct